General Information of Drug (ID: DMEVO6M)

Drug Name
1-Benzyl-2-methyl-1H-imidazole Drug Info
Synonyms
1-Benzyl-2-methyl-1H-imidazole; 1-Benzyl-2-methylimidazole; 13750-62-4; N-Benzyl-2-methylimidazole; Imidazole, 1-benzyl-2-methyl-; 1H-Imidazole, 2-methyl-1-(phenylmethyl)-; EINECS 237-333-8; 1H-Imidazole, methyl(phenylmethyl)-; 2-methyl-1-benzylimidazole; PubChem9442; ACMC-209ccp; SCHEMBL81625; 1-benzyl-2-methyl imidazole; labotest-bb lt00455538; KSC427M1B; MLS001074953; BDBM7885; AC1Q4X69; AC1L35Z6; CHEMBL1269154; DTXSID4065604; FBHPRUXJQNWTEW-UHFFFAOYSA-N; MolPort-003-931-164; HMS3372N18; ZINC156633; HMS2231D21; SBB058028
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
83699
CAS Number
CAS 13750-62-4
TTD Drug ID
DMEVO6M

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NXN-188 DMMBAIH Migraine 8A80 Phase 2 [2]
NXN-462 DMWVBS2 Headache 8A80-8A84 Phase 2 [3]
L-NIL DM6Y49D N. A. N. A. Terminated [4]
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [5]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [5]
Flavin-Adenine Dinucleotide DM5S4GK Discovery agent N.A. Investigative [5]
Heme DMGC287 Discovery agent N.A. Investigative [6]
Formic Acid DMNFZC6 Discovery agent N.A. Investigative [5]
2'-Monophosphoadenosine 5'-Diphosphoribose DME9S8M Discovery agent N.A. Investigative [5]
6-isobutyl-4-methylpyridin-2-amine DM2XB68 Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Nitric-oxide synthase brain (NOS1) TTZUFI5 NOS1_HUMAN Inhibitor [1]

References

1 N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6495-9.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 ClinicalTrials.gov (NCT01748877) Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia. U.S. National Institutes of Health.
4 Discovery of a series of aminopiperidines as novel iNOS inhibitors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):336-43.
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
6 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
7 Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fl... J Med Chem. 2009 Apr 23;52(8):2443-53.